Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Top 3 High-Potential Altcoins to Watch Before They Surge

Top 3 High-Potential Altcoins to Watch Before They Surge

CryptonewslandCryptonewsland2026/10/19 13:54
By:Cryptonewsland
  • NEAR: ETF inflows and ecosystem growth continue fueling strong bullish momentum.
  • ADA: Rising network activity and whale accumulation support a potential recovery.
  • ZEC: Upcoming NU7 upgrade could drive renewed interest and price appreciation.

The crypto market remains volatile, yet a few altcoins continue to show unusual strength. While many large-cap assets struggle to hold gains, several projects have attracted fresh buying interest and strong network activity. Some benefit from institutional support, while others draw attention through upcoming upgrades and growing adoption. For traders seeking opportunities before the next major move, NEAR Protocol, Cardano, and Zcash stand out as three altcoins worth watching closely in the coming week.

Near Protocol (NEAR)

Top 3 High-Potential Altcoins to Watch Before They Surge image 0 Source: Trading View

NEAR has emerged as one of the strongest performers among top cryptocurrencies. The token gained nearly 8% during the past day and more than 11% over the last week. A year-to-date increase of 245% highlights strong momentum. Current price action also reflects a remarkable recovery from levels below $2 in early September. Several factors support this rally. The recent launch of a spot NEAR ETF by Bitwise introduced fresh institutional demand. Fund inflows require direct purchases of NEAR, which reduces available supply and strengthens buying pressure. Beyond ETF demand, growth within the NEAR ecosystem continues to attract attention. NEAR Intents improves cross-chain transactions, while growing interest in artificial intelligence projects adds another layer of appeal. Combined, these developments create a compelling investment narrative for both retail and institutional participants.

Cardano (ADA)

Top 3 High-Potential Altcoins to Watch Before They Surge image 1 Source: Trading View

Cardano delivered one of the strongest rebounds of the week. ADA climbed to a multi-month high before a sharp market-wide pullback pushed prices lower. Buyers quickly returned, helping the token recover and post gains over the last 24 hours and the past week. What makes Cardano particularly interesting is the gap between price performance and network activity. Despite earlier weakness, daily active addresses increased significantly, suggesting growing user engagement. Such divergences often signal stronger demand beneath the surface. Additional catalysts strengthen the bullish case. Large holders continue accumulating ADA, while the recently launched RealFi initiative expands utility across the ecosystem.

Zcash (ZEC)

Top 3 High-Potential Altcoins to Watch Before They Surge image 2 Source: Trading View

Zcash represents the contrarian opportunity on this list. Recent price action has been weak, with losses during the past week and a sharp decline on Friday. Even so, a gain of more than 130% since the beginning of the year shows strong long-term performance. The biggest attraction lies in the upcoming NU7 network upgrade. Testnet activation already succeeded, and mainnet activation is scheduled for October 20. The upgrade introduces faster shielded transactions, prepares the network for Zcash Shielded Assets, and adds a sustainability mechanism for miners. Major upgrades often attract speculative interest before launch, making the coming week especially important for traders watching momentum shifts.

NEAR stands out because of institutional demand and ecosystem growth. Cardano combines rising network activity with several positive fundamental developments. Zcash offers a higher-risk opportunity driven by a major upgrade catalyst. Together, these three altcoins deserve a place on any crypto watchlist heading into next week.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market